Anna Plym

786 total citations
28 papers, 330 citations indexed

About

Anna Plym is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Anna Plym has authored 28 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Genetics. Recurrent topics in Anna Plym's work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Global Cancer Incidence and Screening (4 papers). Anna Plym is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (12 papers) and Global Cancer Incidence and Screening (4 papers). Anna Plym collaborates with scholars based in Sweden, United States and United Kingdom. Anna Plym's co-authors include Mats Lambe, Lorelei A. Mucci, Kathryn L. Penney, Adam S. Kibel, Anna L.V. Johansson, Lars Holmberg, Gustav Ullenhag, Christopher A. Haiman, Irma Fredriksson and Pär Stattin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Anna Plym

26 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Plym Sweden 12 141 124 53 42 40 28 330
Grace Musto Canada 13 121 0.9× 194 1.6× 39 0.7× 38 0.9× 41 1.0× 26 413
Gabriel Tremblay United States 12 74 0.5× 107 0.9× 84 1.6× 25 0.6× 15 0.4× 84 425
Annelies H. Boekhout Netherlands 11 89 0.6× 303 2.4× 53 1.0× 29 0.7× 61 1.5× 31 497
Per-Olof Thuresson Switzerland 8 98 0.7× 85 0.7× 45 0.8× 19 0.5× 25 0.6× 22 390
Lisel Koepl United States 11 87 0.6× 156 1.3× 58 1.1× 33 0.8× 21 0.5× 12 325
Randy V. Heysek United States 11 242 1.7× 232 1.9× 88 1.7× 29 0.7× 49 1.2× 20 569
E. Chouinard Canada 5 131 0.9× 180 1.5× 97 1.8× 58 1.4× 42 1.1× 12 424
Robin Schaffar Switzerland 10 126 0.9× 196 1.6× 33 0.6× 64 1.5× 61 1.5× 19 338
Chenjie Zeng United States 7 87 0.6× 156 1.3× 46 0.9× 39 0.9× 51 1.3× 12 369
Mary D. Chamberlin United States 10 108 0.8× 260 2.1× 83 1.6× 117 2.8× 31 0.8× 39 469

Countries citing papers authored by Anna Plym

Since Specialization
Citations

This map shows the geographic impact of Anna Plym's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Plym with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Plym more than expected).

Fields of papers citing papers by Anna Plym

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Plym. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Plym. The network helps show where Anna Plym may publish in the future.

Co-authorship network of co-authors of Anna Plym

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Plym. A scholar is included among the top collaborators of Anna Plym based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Plym. Anna Plym is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yiwen, Konrad H. Stopsack, Adam S. Kibel, et al.. (2025). Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors. European Urology Oncology. 1 indexed citations
3.
Pagadala, Meghana S., Asona Lui, Julie A. Lynch, et al.. (2024). Healthy lifestyle and prostate cancer risk in the Million Veteran Program. Cancer. 130(20). 3496–3505. 4 indexed citations
4.
Plym, Anna, Yiwen Zhang, Konrad H. Stopsack, et al.. (2024). Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk. JAMA Network Open. 7(7). e2420034–e2420034. 7 indexed citations
5.
Pagadala, Meghana S., Asona Lui, Julie A. Lynch, et al.. (2024). Agent orange exposure and prostate cancer risk in the million veteran program. Acta Oncologica. 63. 373–378. 1 indexed citations
6.
Seibert, Tyler M., Isla P. Garraway, Anna Plym, et al.. (2023). Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention. European Urology. 83(3). 241–248. 24 indexed citations
7.
Ma, Chaoran, Sigrid Carlsson, Hans Lilja, et al.. (2023). Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer. European Urology Open Science. 50. 27–30. 4 indexed citations
8.
Pagadala, Meghana S., Asona Lui, Julie A. Lynch, et al.. (2023). Healthy lifestyle, Agent Orange exposure, and inherited PCa risk: An analysis of the Million Veteran Program.. Journal of Clinical Oncology. 41(6_suppl). 210–210.
9.
Plym, Anna, Ericka M. Ebot, Konstantina Matsoukas, et al.. (2023). SLCO1B3 and SLCO2B1 genotypes, androgen deprivation therapy, and prostate cancer outcomes: a prospective cohort study and meta-analysis. Carcinogenesis. 45(1-2). 35–44. 3 indexed citations
10.
Plym, Anna, Yiwen Zhang, Konrad H. Stopsack, et al.. (2022). Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years. Clinical Cancer Research. 28(22). 4926–4933. 13 indexed citations
11.
Zhou, Charlie, Andreas Pettersson, Anna Plym, et al.. (2022). Differences in Prostate Cancer Transcriptomes by Age at Diagnosis: Are Primary Tumors from Older Men Inherently Different?. Cancer Prevention Research. 15(12). 815–825. 2 indexed citations
12.
Geng, Jiun‐Hung, Anna Plym, Kathryn L. Penney, et al.. (2022). Metabolic syndrome and its pharmacologic treatment are associated with the time to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 25(2). 320–326. 5 indexed citations
13.
Plym, Anna, Yiwen Zhang, Konrad H. Stopsack, et al.. (2022). A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer. European Urology. 83(4). 343–351. 33 indexed citations
14.
Plym, Anna, Miklós Dióssy, Zoltán Szállási, et al.. (2021). DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men. JNCI Cancer Spectrum. 6(1). 12 indexed citations
15.
Plym, Anna, Mark Clements, Margaretha Voss, et al.. (2020). Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study. BMJ Open. 10(3). e032914–e032914. 2 indexed citations
16.
Plym, Anna, Anna L.V. Johansson, Hannah Bower, et al.. (2020). Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Research and Treatment. 182(3). 699–707. 10 indexed citations
17.
Shang, Ying, Laura Fratiglioni, Anna Marseglia, et al.. (2020). Association of diabetes with stroke and post‐stroke dementia: A population‐based cohort study. Alzheimer s & Dementia. 16(7). 1003–1012. 34 indexed citations
18.
Plym, Anna, Hannah Bower, Irma Fredriksson, et al.. (2018). Loss in working years after a breast cancer diagnosis. British Journal of Cancer. 118(5). 738–743. 11 indexed citations
19.
Plym, Anna, Flaminia Chiesa, Margaretha Voss, et al.. (2016). Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based Study. European Urology. 70(1). 64–71. 14 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026